Cost-effectiveness of cell-based influenza vaccine in France.

Gavazzi G, Paccalin M, Berkovitch Q, Leleu H, Moreau R, Ciglia E, Burlet N, Mould-Quevedo J

Open source

DOI
10.1080/14760584.2024.2417854
Published
2024 Jan-Dec
Container
Expert review of vaccines
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14760584.2024.2417854,
  title = {Cost-effectiveness of cell-based influenza vaccine in France.},
  author = {Gavazzi G and Paccalin M and Berkovitch Q and Leleu H and Moreau R and Ciglia E and Burlet N and Mould-Quevedo J},
  year = {2024},
  journal = {Expert review of vaccines},
  doi = {10.1080/14760584.2024.2417854},
  url = {https://doi.org/10.1080/14760584.2024.2417854}
}

RIS

TY  - JOUR
TI  - Cost-effectiveness of cell-based influenza vaccine in France.
AU  - Gavazzi G
AU  - Paccalin M
AU  - Berkovitch Q
AU  - Leleu H
AU  - Moreau R
AU  - Ciglia E
AU  - Burlet N
AU  - Mould-Quevedo J
PY  - 2024
JO  - Expert review of vaccines
DO  - 10.1080/14760584.2024.2417854
UR  - https://doi.org/10.1080/14760584.2024.2417854
ER  - 

APA

G, G., M, P., Q, B., H, L., R, M., E, C., N, B., & J, M. (2024). Cost-effectiveness of cell-based influenza vaccine in France.. Expert review of vaccines. https://doi.org/10.1080/14760584.2024.2417854

Source records